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Longitudinal neuroimaging investigation of fragile X syndrome
(FXS), the most common cause of inherited intellectual disability
and autism, provides an opportunity to study the influence of
a specific genetic factor on neurodevelopment in the living human
brain. We examined voxel-wise gray and white matter volumes
(GMV, WMV) over a 2-year period in 1- to 3-year-old boys with FXS
(n = 41) and compared these findings to age- and developmentally
matched controls (n = 28). We found enlarged GMV in the caudate,
thalamus, and fusiform gyri and reduced GMV in the cerebellar
vermis in FXS at both timepoints, suggesting early, possibly pre-
natal, genetically mediated alterations in neurodevelopment. In
contrast, regions in which initial GMV was similar, followed by
an altered growth trajectory leading to increased size in FXS, such
as the orbital gyri, basal forebrain, and thalamus, suggests
delayed or otherwise disrupted synaptic pruning occurring post-
natally. WMV of striatal-prefrontal regions was greater in FXS
compared with controls, and group differences became more ex-
aggerated over time, indicating the possibility that such WM ab-
normalities are the result of primary FMRP-deficiency-related
axonal pathology, as opposed to secondary connectional dysregu-
lation between morphologically atypical brain structures. Our
results indicate that structural abnormalities of different brain
regions in FXS evolve differently over time reflecting time-depen-
dent effects of FMRP deficiency and provide insight into their neu-
ropathologic underpinnings. The creation of an early and accurate
human brain phenotype for FXS in humans will significantly im-
prove our capability to detect whether new disease-specific treat-
ments can “rescue” the FXS phenotype in affected individuals.
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Fragile X syndrome (FXS) is themost common cause of inheritedintellectual disability. The condition is caused by expansion of
the CGG repeat in the 5′-untranslated region of the fragile X
mental retardation 1 (FMR1) gene, resulting in hypermethylation,
transcriptional silencing, and reduction or loss of the gene product,
the fragile X mental retardation protein (FMRP) (1). Loss of
FMRP disrupts dendritic maturation, synaptic plasticity, and cere-
bral development (2). Although much is understood about the
typical pattern of cerebral abnormality in adults and older children
with FXS, relatively little is known about the evolving nature of
these abnormalities in early childhood. One of the most consistent
observations in FXS is enlargement of the caudate nucleus, which
has been noted in children as young as 18 months (3), relative to
both typically developing children and those with idiopathic de-
velopmental delay (4). Increased caudate size also shows a negative
correlation with FMRP, indicating a genetic dose–response re-
lationship (4, 5). Another consistent finding is reduced size of the
cerebellar vermis, which has been observed in FXS across a wide
range of ages (4–7). Vermis size has been shown to be positively
correlatedwithFMRP (5), although in our recent studywith amore
restricted and young age range (ages 1 to 3), this correlationwas not
observed (4).
Such observations suggest that the FMR1 mutation and con-
sequent reductions in FMRP levels differentially affect the de-
velopment of several brain structures. Synapse development,
including maturation and pruning, occurs in waves throughout
the brain, both pre- and postnatally, and brain regions may un-
dergo this process at different rates (8). Deficient FMRP results
in synaptic abnormalities, namely long, thin dendritic spines
characteristic of early development (9, 10). Further, recent re-
search in the mouse model of FXS suggests that FMRP plays
a critical role during specific periods of cortical development,
particularly for regions related to sensory processing (11). The
results of this study emphasize the importance of defining critical
windows of brain development during which targeted therapy
might be most effective.
Taken together, findings to date indicate that certain brain
regions are differentially sensitive to the impact of FMRP rela-
tive to others, and the maturational period(s) during which
FMRP plays a critical role in brain development may differ from
region to region. Increasingly divergent trajectories of neuro-
development leading to regional enlargement after birth, for
example, may represent a lack of synaptic pruning and matura-
tion postnatally, whereas persistent regional diminution present
from birth might be related to earlier, prenatal effects resulting
from deficient FMRP. Thus, it could be hypothesized that re-
gional differences in brain volumes in FXS could serve as tem-
poral markers of FMRP’s impact on neurodevelopment.
To address these questions, we examined longitudinal changes
in regional gray and white matter volumes (GMV and WMV,
respectively) by using modulated voxel-based morphometry
(VBM) and Diffeomorphic Anatomical Registration Through
Exponentiated Lie Algebra (DARTEL). Participants were 1- to
3-year-old boys [mean = 2.79, SD = 0.63) with FXS (n = 41) or
matched-controls [typically developing (TD): n = 21; idiopathic
developmental delay (DD): n = 7] who were followed up for an
average of 2.03 years (SD = 0.37) (Table 1; regional brain vol-
umes for TD and DD reported separately in Table S1).
Results
Whole-brain voxel-wise analysis showed a main effect of time
with GMV increasing over time in most regions (Fig. 1A). No
region showed significant decrease in GMV over time. There was
a main effect of diagnosis with FXS showing significantly greater
GMV compared with TD/DD controls in bilateral caudate and
also in the nucleus accumbens, putamen, thalamus, hypothala-
mus, dorsomedial, dorsolateral and ventrolateral prefrontal
cortices, and parieto-temporal and occipito-temporal regions,
including fusiform gyri, and culmen and declive of the cerebel-
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lum (Fig. 1B, red and yellow; peaks reported in Table S2). In the
opposite direction, FXS showed reduced GMV compared with
TD/DD controls strongly in bilateral insula but also in pre-
cuneus/posterior cingulate and posterior cerebellar vermis (Fig.
1B, blue and cyan; peaks reported in Table S2). There was also
an interaction effect where FXS showed significantly greater
Fig. 1. Differences in regional gray matter volume between groups and over time. (A) Regions that show a significant main effect of time. (B) Regions that
show a significant main effect of diagnosis (red and blue) and a significant interaction effect (green). (C) As an example, regional volume of the caudate body
that showed an interaction effect is extracted and plotted for each group. (D) Same data but slope of caudate volume is plotted for each group. (E) Regions
highlighted in B are plotted as examples of main effect of diagnosis (FXS > TD/DD, caudate head, TD/DD > FXS, posterior vermis) and interaction effects
(nucleus basalis, thalamus). Note that the nucleus basalis, cerebellum, and hippocampus are regions with enhanced FMR1 expression during development.
DD, blue; TD, black; FXS, red. Time1 age, total GMV, and scan-site are entered as nuisance variables. P = 0.05 corrected.
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increase in GMV over time compared with TD/DD controls in
the following regions: bilateral thalamus, hypothalamus, a small
portion of the caudate body, nucleus basalis, amygdala, nucleus
accumbens, dorsomedial (superior frontal and medial frontal
gyri), dorsolateral (middle frontal gyrus), ventromedial (rectal
and orbital gyri) and ventrolateral prefrontal cortices (inferior
frontal gyrus), temporal (superior, middle, and inferior tempo-
ral gyri) and occipital regions, including fusiform gyri, and cul-
men and declive of the cerebellum (Fig. 1B, green, yellow, and
cyan; peaks reported in Table S2). There were no other signif-
icant interaction effects.
In the white matter (WM), there was also a main effect of
time with WM increasing over time in most WM regions (Fig.
2A). No regions showed significant decrease in WMV over time.
There was a main effect of diagnosis with FXS showing greater
WMV compared with TD/DD controls in bilateral fronto-
striatal and medial temporal regions (Fig. 2B, red and yellow;
peaks reported in Table S2). In the opposite direction, FXS
showed reduced WMV compared with TD/DD controls in lat-
eral central regions (Fig. 2B, blue and cyan; peaks reported in
Table S2). There was also an interaction effect where FXS
showed a significantly greater increase in WMV over time
compared with TD/DD controls. These regions included bi-
lateral dorsal and ventral frontal and fronto-striatal regions and
posterior temporal and temporal pole regions (Fig. 2B, green,
yellow, and cyan; peaks reported in Table S2). There were no
other types of interaction effects.
Discussion
In this study, we examined brain MRIs from a longitudinal co-
hort of young boys with FXS and age- and developmentally
matched controls to characterize changes in regional brain vol-
umes over time. Our findings of larger GMV in the caudate and
fusiform gyri replicate prior studies of older individuals with FXS
(5, 12–14), indicating that these adult-like abnormalities are
present from an early age (1-3 years). In these regions, which in
our study were larger in FXS at both timepoints, an early, pos-
sibly prenatal, alteration of neurodevelopment is likely. On the
other hand, regions in which the rate of GMV change was greater
in FXS than in controls, such as the orbital gyri, basal forebrain,
and large segments of the thalamus, may suggest delayed or
otherwise disrupted synaptic pruning occurring postnatally, be-
cause GMVs in these areas were initially similar in FXS and
controls but became relatively larger in FXS by 3–5 years of age
(second timepoint).
WMV changes were noted mainly in tracts running through
prefrontal, temporal, and central regions. Differences in these
regions may indicate abnormal connectivity as a result of ab-
normalities in the connected regions themselves or may repre-
sent a primary defect of white matter development. Although in
the present study these regions were not characterized by trac-
tography, they do share a positional similarity to tracts that have
been reported to be abnormal in FXS, including ventral fron-
tostriatal pathways, which show reduced fractional anisotropy
and fiber density, the latter of which is associated with lower
intelligence quotient in these individuals (15). As WMV in
ventral prefrontal tracts increased over time at a greater rate in
FXS, and because FMRP is thought to regulate axonal de-
velopment (16) and possibly myelination (17), it is conceivable
that white matter abnormalities in ventral frontostriatal tracts in
FXS are the result of primary FMRP-deficiency-related axonal
pathology, as opposed to secondary connectional dysregulation
between morphologically atypical brain structures.
It is noteworthy that several regions, which showed differential
rates of volume change over time, are known to be rich in FMRP
expression, namely the cerebellum, hippocampus, and basal
forebrain (nucleus basalis) (18). Curiously, these regions did not
show similar rates of volume change over time. It is therefore
possible that the neuroanatomic profile in FXS depends not only
on the level of FMRP expression in a given brain structure, but
Fig. 2. Differences in regionalWMVbetween groups and over time. (A) Regions that show a significant main effect of time. (B) Regions that show a significant
main effect of diagnosis (red andblue) and a significant interaction effect (green). Time1 age, totalWMV, and scan-site are entered as nuisance variables. P=0.05
corrected.











also the differential effects of FMRP on synaptogenesis, den-
dritic outgrowth, and pruning at various points during the neu-
rodevelopmental process. For example, GMV in the cerebellar
vermis was found to be consistently smaller in FXS at both
timepoints but changing over time at similar rates to controls.
This result suggests that FMRP plays a critical role in this region
during a relatively early period, before age 1–3 years and possibly
during prenatal neurodevelopment. In the basal forebrain, an-
other region rich in FMRP (18), volumetric differences in gray
matter are not seen until later in childhood, indicating that
FMRP’s critical period of activity in this region is postnatal,
likely occurring within the 3- to 5-year range.
In addition to further characterizing the neuroanatomic pro-
file of FXS by extending observations to include longitudinal
assessments of very young children, our study provides a basis
upon which interventions aimed at curtailing abnormal neuro-
development can be assessed. Taken together, our results sug-
gest that the neuroanatomic abnormalities of FXS are not laid
out simultaneously but rather occur at different times in different
regions, consistent with patterns of cortical development (8) and
site-specific activity of FMRP (9, 19–21), likely representing
a combination of pre- and postnatal processes. As such, it may be
possible to track the efficacy of interventional strategies, such as
metabotropic glutamate receptor antagonists (22), over time and
in specific brain structures, with an understanding of the expec-
ted neurodevelopmental course in those structures.
Although our study provides exciting preliminary evidence into
the developmental changes of neuroanatomical profiles in FXS,
there are important issues that could be addressed in future studies.
First, future studies should include larger samples of controls, in
particular of individuals with idiopathic DD so that TD and DD
controls could be examined separately. Second, tracking de-
velopment from a younger age and at multiple timepoints for
a longer period is desirable. Third, it may be of interest to compare
FXS with another population that has genetic abnormalities that
affect brain development and some overlap in cognitive abnor-
malities such asWilliams syndrome. Fourth, we did not use manual
or atlas-based anatomical parcellation methods to characterize
between-group differences in brain development. Utilization of
such methods could provide interesting complementary data in
a subsequent study of brain development in FXS. However, use of
manual oratlas-basedmethodswouldbeunlikely toconvergeon the
same results as those shown here, because the cortical and sub-
cortical regions showing significant between-group differences with
VBM do not correspond to traditional anatomical boundaries.
These data provide the beginnings of brain region-specific
developmental trajectories in FXS, reflecting time-dependent
effects of FMRP deficiency. Our results indicate that some adult-
like patterns of structural abnormalities are present in very
young children with FXS, whereas other abnormalities evolve
over time differently. It is also notable that our finding of aber-
rant neurodevelopmental trajectories in the thalamus and cortex
of young boys with FXS (Fig. 1B) is consistent with the recent
report of FMRP effects on excitatory thalamocortical synapses in
the somatosensory cortex of the FXS animal model (11). Such
data provide insight into the neuropathologic effects of reduced
FMRP in early development and underscores the need for lon-
gitudinal examination of brain morphology in this population.
Lastly, this basic neuroanatomic developmental profile may aid
in targeting and evaluating therapeutic modalities that could
rescue the FXS phenotype in affected individuals.
Materials and Methods
Participants and Cognitive Assessment. Participants for this study were
recruited by Stanford University School ofMedicine (SU) and the University of
North Carolina-Chapel Hill (UNC). The study protocols were approved by the
human subjects committees at SU and UNC, and consent was obtained. TD
and DD children were recruited through local intervention programs, pre-
schools, childcare facilities, community media, and state-run agencies (e.g.,
Regional Center system in California and Child Development Service Agencies
in North Carolina). Children with FXS were recruited through registry
databases maintained by Stanford and UNC, postings to the National Fragile
X Foundation website and quarterly newsletter, and mailings to other re-
gional fragile X organizations. Participants were excluded from the study if
they were born preterm (<34 weeks), had a low birth weight (<2,000 grams),
showed evidence of a genetic condition or syndrome, exhibited sensory
impairments or had any serious medial or neurological condition that af-
fected growth or development (e.g., seizure disorder, diabetes, congenital
heart disease). Children in the DD group comprised developmental delays of
unknown etiology (with a composite standard score <85 on the Mullen
Scales of Early Learning) did not exhibit symptoms indicating an autism
spectrum disorder or any symptoms indicative of another developmental
disorder (e.g., Down syndrome, Williams syndrome). TD and DD children
were screened for autism spectrum disorders by using the Childhood Autism
Rating Scale (CARS). All children in these groups scored below the cutoff for
the nonautistic range (<30). Details regarding demographic information and
distribution of sample between recruitment sites can be found in Table 1. All
participants were given a standard battery of cognitive, adaptive, and be-
havioral measures that included the Mullen Scales of Early Learning (23).
There were no significant differences between sites in any of the cognitive
measurements for each diagnostic group or when all groups were combined
(all P > 0.05).
Genotype. All children in the FXS and DD groups underwent DNA testing for
the typical FMR1 expansion mutation. This testing confirmed the presence of
the mutation in children in the FXS group and ruled out FXS as a cause of
delay in the DD groups. To assess the presence of the fragile X mutation,
standard Southern blot analysis was performed, followed by FMR1-specific
probe hybridization (24). To quantify FMRP expression, the percentage of
peripheral lymphocytes containing FMRP was calculated by using immu-
nostaining techniques (25).
MRI Scanning Procedures. Imaging data were acquired between April 2000
and May 2008 at SU (Lucile Packard Children’s Hospital) and UNC (Brain
Imaging and Analysis Center) by using identical pulse sequences and scan-
ners (General Electric 1.5-T Signa scanner; GE Imaging Systems) at both sites.
The pulse sequences used were designed to maximize contrast among GM,
WM, and cerebrospinal fluid for the participants’ age range. Images ac-
quired included a coronal T1-weighted sequence (inversion recovery prep-
aration pulse = 300 ms; repetition time = 12 ms; echo time = 5 ms; flip angle
= 20°; slice thickness = 1.5 mm; number of excitations = 1; field of view = 20
cm; matrix = 256 × 192). A MR quality control phantom was scanned after
each participant at both sites to standardize assessment over sites, individ-
uals, and time. Children in the FXS and DD groups were sedated during the
MRI. Sedation was administered by a pediatric anesthesiologist, and children
were monitored continually during the MRI procedure. TD children were
scanned while sleeping, at a time that was later than the participant’s
normal bedtime. In addition, for the sleep scans, parents were asked to wake
their child up slightly earlier on the morning of the scan, and to shorten nap
time that day, to increase the likelihood of the child sleeping through the
entire scan. To prepare for the scan, families received a packet of materials,
including a compact disc of scanner noises designed to sensitize him/her to
the scanner sounds. TD children also participated in a simulated MRI session
at the laboratory in which they were asked to practice holding still and to
mitigate fear should the child awaken during the MRI.
Cross-Site Analysis. To maximize scan compatibility across sites, identical pulse
sequences and scanners were used at the two collection sites. In addition, to
characterize scanner quality and signal-to-noise ratio (SNR) during our study,
we collected phantom scans after each participant. During the course of the
study, 24 random phantom scans (12 per scanner, selected across the entire
period of the study by a research assistant blind to scans) were used by the
method described in ref. 26. Two SNR measurements were performed and
were not significantly different across sites (P = 0.39 and P = 0.22, respectively).
We also assessed whether brain volumes within each group differed as
a function of scan site. No tissue type [GMV, WMV, or total tissue volume
(TTV)] was significantly different across sites (all P > 0.05). Finally, we included
scan site as a nuisance variable in all reported analyses to mitigate small
(nonsignificant) differences found between sites. For more details, see ref. 4.
VBM Processing. VBM analyses of MR images were carried out by using the
SPM5 statistical package (http://www.fil.ion.ucl.ac.uk/spm), including the
DARTEL toolbox (27) andVBM5.1 (http://dbm.neuro.uni-jena.de/vbm). Images
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were bias-field corrected and segmented to GM, WM, and CSF by using
VBM5.1and custompriors created fromall scans. The imageswerenormalized
by using the DARTEL toolbox and then to MNI space following the DARTEL
guide, which resulted in modulated GM and WM images. Smoothing was
performedwith an isotropic Gaussian kernel with full-width at half-maximum
of 8mm. For eachparticipant, segmentation andnormalization accuracywere
manually inspected.
Analyses of Total GM Volume (TGMV), Total WM Volume (TWMV), and Total
Tissue Volume (TTV). We examined TGMV, TWMV, and TTV (GMV + WMV)
differences between TD, DD, and FXS groups, using values obtained from VBM
processingbyusinganalysisof covariance(ANCOVA), covaryingoutageandsite.
Analyses of Regional GMV and WMV. Regional GMV and WMV differences
between FXS and controls (TD and DD combined) at time 1 and time 2 were
examined by usingwhole-brain 2 (time)× 2 (group, FXS, and TD +DD) repeated
measures ANCOVA, covarying out age, site, duration between times 1 and 2,
and TGMV/TWMV for GM and WM analyses, respectively. TD and DD groups
were initially grouped together because of the small n. Main effect of time,
diagnosis, and interaction effects were examined. A statistical threshold of P =
0.05 false discovery rate (FDR), extent threshold = 200 voxels, was used (28) and
was corrected for nonisotropic smoothness (29, 30). Statistical images were
overlaid on the average GM and WM images from all subjects, using MRIcron
(www.sph.sc.edu/comd/rorden/mricron/). Talairach coordinates of peaks of sig-
nificant clusters were converted fromMNI space by using the mni2tal function
(www.mrc-cbu.cam.ac.uk/Imaging/Common/mnispace.shtml). Talairach Dae-
mon (Research Imaging Center, University of Texas Health Science Center) and
the atlas by Talairach and Tournoux (31) were initially used to identify Brod-
mann Areas. The final anatomic locations are reported according to their ana-
tomic location overlaid on the custom template.
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